1621 Central Avenue
Cheyenne, WY 82001
United States
206-734-4738
https://www.evbiologics.com
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 284
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Daniel S. McKinney | Founder, Chairman & CEO | S.O. | S.O. | 1962 |
Mr. Monte Fisher | Chief Financial Officer | S.O. | S.O. | S.O. |
Mr. William Bossung | Corporate Finance Director & Corporate Secretary | S.O. | S.O. | S.O. |
EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.
L’ISS Governance QualityScore de EV Biologics, Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..